Tenders Are Invited For Medicinal Products For The Blood And Blood-Forming Organs – Hemofilie A - Rekombinantní Faktor Viii. 2026

Medicinal Products For The Blood And Blood-Forming Organs – Hemofilie A - Rekombinantní Faktor Viii. 2026. Coagulation Factor Viii - Recombinant Esperoct For Unmedicated Patients From 13 Years Of Age Who Are Pretreated With Fviii From Plasma Or Rfviii Min 150 Exposure Days,Hemophilia A - Coagulation Factor Viii - Recombinant With A Longer Biological Half-Life - For Patients From 13 Years Of Age Who Are Pretreated With Fviii From Plasma Or Rfviii Min 150 Exposure Days,Hemophilia A-Coagulation Factor Viii - Recombinant With A Longer Biological Half-Life - For Patients From 13 Years Of Age Without Pretreatment With Fviii From Plasma Or Rfviii,Hemophilia A-Coagulation Factor Viii - Recombinant With A Longer Biological Half-Life-For Patients Under 12 Years,Recombinant Preparations For The Prevention And Treatment Of Bleeding In Hemophilia A, Also In Patients With Hemophilia A With An Inhibitor Against Fviii (Titer Up To 5 Bu) 3Rd And Higher Generation